Insulin activity on RCC cells is a result of the phenomenon that both receptors - IR and IGFR, as well as their heterodimers - can bind all three ligands (insulin, IGF1I and IGF2), although with varying affinities. The gene discussed is IGF2; the disease is renal cell adenocarcinoma.